Page last updated: 2024-11-01

olprinone and Anoxemia

olprinone has been researched along with Anoxemia in 4 studies

olprinone: RN refers to HCl; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Olprinone does not affect the hypoxia-induced dilatation of pial arterioles in pentobarbital anesthetized rabbits."7.72Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits. ( Miyabe, M; Tajima, K; Takahashi, H; Toyooka, H, 2003)
" The authors examined whether olprinone, a phosphodiesterase III inhibitor, protected functional and structural integrity of gut mucosa against acute progressive hypoxia."7.72Olprinone, a phosphodiesterase III inhibitor, reduces gut mucosal injury and portal endotoxin level during acute hypoxia in rabbits. ( Ai, K; Kosugi, S; Kotake, Y; Morisaki, H; Satoh, T; Serita, R; Takeda, J; Yamamoto, M, 2003)
"To examine acute effects of olprinone hydrochloride (CAS 106730-54-0, Coretec) on pulmonary hypertension, hypoxic pulmonary hypertension was produced in 6 adult Beagle dogs."7.70Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension. ( Amitani, S; Kakura, H; Koga, M; Misumi, K; Miura, N; Miyahara, K; Sakamoto, H; Sohara, H, 2000)
"Olprinone does not affect the hypoxia-induced dilatation of pial arterioles in pentobarbital anesthetized rabbits."3.72Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits. ( Miyabe, M; Tajima, K; Takahashi, H; Toyooka, H, 2003)
" The authors examined whether olprinone, a phosphodiesterase III inhibitor, protected functional and structural integrity of gut mucosa against acute progressive hypoxia."3.72Olprinone, a phosphodiesterase III inhibitor, reduces gut mucosal injury and portal endotoxin level during acute hypoxia in rabbits. ( Ai, K; Kosugi, S; Kotake, Y; Morisaki, H; Satoh, T; Serita, R; Takeda, J; Yamamoto, M, 2003)
"To examine acute effects of olprinone hydrochloride (CAS 106730-54-0, Coretec) on pulmonary hypertension, hypoxic pulmonary hypertension was produced in 6 adult Beagle dogs."3.70Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension. ( Amitani, S; Kakura, H; Koga, M; Misumi, K; Miura, N; Miyahara, K; Sakamoto, H; Sohara, H, 2000)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamamoto, H1
Miyabe, M1
Tajima, K1
Takahashi, H1
Toyooka, H1
Satoh, T1
Morisaki, H1
Ai, K1
Kosugi, S1
Yamamoto, M1
Serita, R1
Kotake, Y1
Takeda, J1
Kakura, H1
Miyahara, K1
Amitani, S1
Sohara, H1
Koga, M1
Sakamoto, H1
Misumi, K1
Miura, N1

Other Studies

4 other studies available for olprinone and Anoxemia

ArticleYear
[The effect of PDEIII inhibitors and colforsin daropate on hypoxic pulmonary vasoconstriction in rabbit lungs].
    Masui. The Japanese journal of anesthesiology, 2008, Volume: 57, Issue:11

    Topics: Animals; Colforsin; Hypoxia; Imidazoles; In Vitro Techniques; Male; Milrinone; Phosphodiesterase Inh

2008
Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2003, Volume: 50, Issue:2

    Topics: Animals; Arterioles; Blood Gas Analysis; Blood Pressure; Cerebrovascular Circulation; Heart Rate; Hy

2003
Olprinone, a phosphodiesterase III inhibitor, reduces gut mucosal injury and portal endotoxin level during acute hypoxia in rabbits.
    Anesthesiology, 2003, Volume: 98, Issue:6

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Carbon Dioxide; Cyclic Nucleotide Phosp

2003
Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension.
    Arzneimittel-Forschung, 2000, Volume: 50, Issue:6

    Topics: Animals; Blood Gas Analysis; Cardiac Output; Cardiotonic Agents; Dogs; Hemodynamics; Hypertension, P

2000